惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

NISL@THU
NISL@THU
Latest news
Latest news
Scott Helme
Scott Helme
T
Tenable Blog
Simon Willison's Weblog
Simon Willison's Weblog
T
The Exploit Database - CXSecurity.com
C
CERT Recently Published Vulnerability Notes
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
博客园 - 司徒正美
K
Kaspersky official blog
The Hacker News
The Hacker News
Jina AI
Jina AI
C
CXSECURITY Database RSS Feed - CXSecurity.com
C
Cisco Blogs
S
Secure Thoughts
雷峰网
雷峰网
Project Zero
Project Zero
T
Troy Hunt's Blog
IT之家
IT之家
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
博客园 - Franky
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
Know Your Adversary
Know Your Adversary
爱范儿
爱范儿
博客园 - 聂微东
N
News and Events Feed by Topic
The Cloudflare Blog
博客园_首页
阮一峰的网络日志
阮一峰的网络日志
D
Darknet – Hacking Tools, Hacker News & Cyber Security
AI
AI
Schneier on Security
Schneier on Security
Recent Announcements
Recent Announcements
博客园 - 三生石上(FineUI控件)
大猫的无限游戏
大猫的无限游戏
The Last Watchdog
The Last Watchdog
L
LINUX DO - 热门话题
Vercel News
Vercel News
C
Check Point Blog
Cisco Talos Blog
Cisco Talos Blog
Apple Machine Learning Research
Apple Machine Learning Research
量子位
C
Cyber Attacks, Cyber Crime and Cyber Security
TaoSecurity Blog
TaoSecurity Blog
B
Blog RSS Feed
MongoDB | Blog
MongoDB | Blog
P
Proofpoint News Feed
P
Palo Alto Networks Blog
云风的 BLOG
云风的 BLOG

Forbes - Healthcare

How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
Nina Schwalbe In Run For Congress Finds These Barriers To Scientists
Bruce Y. Lee · 2026-06-21 · via Forbes - Healthcare
Nina Schwalbe

Longtime public health professional Nina Schwalbe, MPH, (pictured here to the right) is running to succeed retiring U.S. Rep. Jerry Nadler (D) as the representative for Manhattan’s 12th Congressional District. (Photo: Maxim Shapovalov)

Maxim Shapovalov

It’s simple. In what’s supposed to be a democracy, if you want the government to do more to help the health and well-being of the people, you can just run for Congress yourself and get elected, right? Well, that‘s essentially what longtime public health professional and leader Nina Schwalbe, MPH, has indicated she wants to do in running to succeed retiring U.S. Representative Jerry Nadler (D) as the representative for Manhattan’s 12th Congressional District. But as a science-based candidate who is quite different from traditional members of Congress, Schwalbe has been running into a bunch of obstacles and barriers that may be keeping scientists in general from reaching Congress.

Schwalbe Was First Motivated By Trump Administration’s Cuts To Public Health And Lack Of Congressional Action

“What first motivated me to run for Congress is when [U.S. President Donald] Trump withdrew the U.S. from the World Health Organization and fired 200,000 plus of our peers from CDC, NIH, FDA and USAID, who all do basic functions that are required to keep people safe and healthy,” Schwalbe told me. “And then when I tried to call our Congress people, they just weren’t paying attention.” I’ve continued to cover in Forbes such ongoing cuts in both funding and personnel as well as the U.S. withdrawal from the WHO. funding threats to universities and questions about policies made by Secretary of Health Human Services Robert F. Kennedy, Jr.

Schwalbe herself has decades of experience in public health leadership positions, ranging from being the director of policy at the Global Alliance for TB Drug Development to serving as the deputy executive secretary and managing director for policy and performance at GAVI to working as UNICEF’s principal advisor and acting chief of health. Faith McLellan described Schwalbe as a “global health expert and advocate” who “has spent her career working on multifaceted global health issues, ranging from HIV and tuberculosis prevention to negotiations for a pandemic treaty,” in a recent article in the leading scientific journal The Lancet, which isn’t exactly where you typically find articles about Congressional candidates. So Schwalbe has kind of known well what laying off all those science and health professionals from U.S. government agencies will eventually do to the health of many Americans.

Problems In Identifying The Cause Of An Infectious Outbreak Further Motivated Schwalbe To Run For Congress

What further “infected” Schwalbe with the idea to run for Congress was an unexplained infectious disease outbreak in the Democratic Republic of Congo that occurred in February-to-March of 2025. She noticed problems in identifying the specific virus that was causing the outbreak, which should be kind of concerning given that little thing called the COVID-19 pandemic that happened oh just a few years ago.

“So I tried to call our Congress people, and they just weren’t listening, they didn’t care,” Schwalbe recalled. "Finally, I got [U.S. Senator Kirsten] Gillibrand’s office because she’s on the Senate foreign relations committee and has a particular interest in DRC. Then, they called the CDC, then engaged with the WHO, but that took way too many calls." Schwalbe added, “With a lot of experiences added up like that, I realized that they had lost the plot. Nobody was following this.”

That became the straw that got her over the camel’s hump, so to speak. “I started to think about [running for Congress] in spring 2025 and over the summer, and then I thought I would run as just a challenger to Nadler to bring up public health, to raise these issues on mistakes,” Schwalbe detailed for me. “Then Nadler decided to step down and then the whole thing changed. I spoke with a bunch of people who said I should run because we needed this voice.”

You know the song Wake Me Up When September ends. Well, it was September 2025 when Schwalbe decided in earnest to run for Congress. She then entered a Democrat field that is currently led by four men who have much more traditional backgrounds as political candidates. Two of them are current New York Assemblymembers: Micah Lasher and Alex Bores. One of them is a former Republican, who garnered a fair amount of press when he turned anti-Trump despite his wife’s position in the first Trump administration: George Conway. And the last of the four, Jack Schlossberg, happens to be the grandson of President John F. Kennedy.

People Have Told Schwalbe That More Scientists Are Needed In Congress

It doesn’t take a scientific study to realize that scientists in general comprise only a very small percentage of the 119th U.S. Congress. For example, of the 535 voting members of Congress, only nine are engineers, one is a physicist, one is a chemist, one is a geologist and 30 are physicians. Every day Congress makes decisions that are science-related with direct scientific experience and knowledge in such short supply. Isn’t that kind of like getting a bunch of non-athletes to play for the U.S. FIFA World Cup team?

Schwalbe emphasized how scientists “are really good at solving complex problems. And that’s an approach which is helpful across multiple fields. Our method of inquiry is really helpful and I don’t think people really appreciate that.” She expressed concerns that politicians won’t necessarily know what laws need to be passed in health and public health, “how such laws should be implemented and how do you check and make sure that they’re implemented with the intended effect.”

And the cuts to science and health made by the Trump administration have certainly cut across many different sectors in many different ways. “Almost everybody I speak to is concerned that science has been cut,” Schwalbe related to me. She spoke of people losing jobs, not being able to find jobs, labs and studies getting cut, and “stories all day about ‘grandma was in a clinical trial for a treatment, and the trial was stopped midstream.” She told me, “People will stop and say, ’Oh, you’re the scientist. We need a scientist. We need a scientist in Congress.”

Schwalbe Found How Much Money And Connections Talk When Running For Congress

Nancy Goroff, PhD, a former chair of the chemistry department at Stony Brook University ran for the New York’s 1st congressional district seat in 2020 but lost to the incumbent, Lee Zeldin (Photo by Chris Ware/Newsday RM via Getty Images)

Newsday via Getty Images

Scientists may have problem-solving skills, insight and knowledge in abundance. But one thing they may not have in abundance is moolah, which is a technical term for money. “When I asked people how much money would I need to raise, a lot of people said like $3 million,” Schwalbe recalled. “I was like, well, that’s not gonna happen.” She indicated that everyday people “don’t realize how much of a money run enterprise politics and running for office is, and it's really crummy.”

The other big “c” besides “cash” and “crummy” is “connections.” Schwalbe lamented, “It’s really about whom you know, as all the endorsements come from people. You had to have had long relationships with people. There’s no sort of fair playing field here.”

Nancy Goroff, PhD, a former chair of the chemistry department at Stony Brook University who also ran for the New York’s 1st congressional district seat in 2020 but lost to the incumbent, Lee Zeldin confirmed Schwalbe’s observations: “In order to get elected, one needs to raise millions of dollars. Candidates with large networks of wealthy friends are at a huge advantage, and most scientists do not have that kind of network.”

Scientists Like Schwalbe Face Additional Barriers To Get Into Congress

Angela Merkel (R), who served as chancellor of Germany from 2005 to 2021, holds a doctorate in quantum chemistry and spent over a decade working as a research scientist in East Germany before transitioning into politics. (Photo by CHRISTIAN HARTMANN/POOL/AFP via Getty Images)

POOL/AFP via Getty Images

Besides money, Schwalbe mentioned another “m” that can be a big barrier for scientists: machine “The Democratic machine is very much about protecting current interests,” she said. “There’s a lot of quid pro quo and deal making. And public health is so invisible. People really don’t understand what it is or how it works.”

Goroff pointed out something else “s”-y about what scientists have to face, namely stereotypes. “Scientists running for office also have to contend with the stereotypes that voters and donors have about what a scientist is," Goroff related. "There are positive associations and negative with being a scientist, and since there are so few in politics, any science candidate has to carry all those stereotypes, whether or not they fit.” Such stereotypes are like the components fruitcakes in that they’re nuts in that they don’t match reality but can weigh down the candidacies of scientists for leadership positions. In reality, you can find many world leaders past and present with deep scientific backgrounds such as the current presidents of Mexico (Claudia Sheinbaum) and China (Xi Jinping) the former chancellor of Germany (Angela Merkel) and of course many of the U.S.’s Founding Fathers like Benjamin Franklin Thomas Jefferson, John Adams, James Madison and George Washington.

Yeah, that last bunch of scientists was kind of successful in founding and growing this whole America thing. Why then wouldn’t people find scientists to be effective at leading it now?